Correlation Between Cns Pharmaceuticals and Royalty Pharma

Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cns Pharmaceuticals and Royalty Pharma Plc, you can compare the effects of market volatilities on Cns Pharmaceuticals and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Royalty Pharma.

Diversification Opportunities for Cns Pharmaceuticals and Royalty Pharma

0.45

Correlation Coefficient

Cns Pharmaceuticals  Royalty Pharma

Very weak diversification

The 3 months correlation between Cns and Royalty is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Royalty Pharma go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and Royalty Pharma

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 3.1 times more return on investment than Royalty Pharma. However, Cns Pharmaceuticals is 3.1 times more volatile than Royalty Pharma Plc. It trades about 0.14 of its potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.04 per unit of risk. If you would invest  11.00  in Cns Pharmaceuticals on October 9, 2024 and sell it today you would earn a total of  1.00  from holding Cns Pharmaceuticals or generate 9.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cns Pharmaceuticals  vs.  Royalty Pharma Plc

Cns Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cns Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Cns Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Royalty Pharma Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Royalty Pharma Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Royalty Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cns Pharmaceuticals and Royalty Pharma

The main advantage of trading using opposite Cns Pharmaceuticals and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.

The idea behind Cns Pharmaceuticals and Royalty Pharma Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.